THE ADENOVIRUS E3 10.4K AND 14.5K PROTEINS, WHICH FUNCTION TO PREVENTCYTOLYSIS BY TUMOR-NECROSIS-FACTOR AND TO DOWN-REGULATE THE EPIDERMALGROWTH-FACTOR RECEPTOR, ARE LOCALIZED IN THE PLASMA-MEMBRANE

Citation
Ar. Stewart et al., THE ADENOVIRUS E3 10.4K AND 14.5K PROTEINS, WHICH FUNCTION TO PREVENTCYTOLYSIS BY TUMOR-NECROSIS-FACTOR AND TO DOWN-REGULATE THE EPIDERMALGROWTH-FACTOR RECEPTOR, ARE LOCALIZED IN THE PLASMA-MEMBRANE, Journal of virology, 69(1), 1995, pp. 172-181
Citations number
60
Categorie Soggetti
Virology
Journal title
ISSN journal
0022538X
Volume
69
Issue
1
Year of publication
1995
Pages
172 - 181
Database
ISI
SICI code
0022-538X(1995)69:1<172:TAE1A1>2.0.ZU;2-B
Abstract
The adenovirus type 2 and 5 E3 10,400- and 14,500-molecular-weight (10 .4K and 14.5K) proteins are both required to protect some cell lines f rom lysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor. We have shown previously that both 10.4K and 1 4.5K are integral membrane proteins and that 14.5K is phosphorylated a nd O glycosylated. The 10.4K protein coimmunoprecipitates with 14.5K, indicating that the two proteins function as a complex. Here we show, using immunofluorescence and two different cell surface-labeling techn iques, that both proteins are localized in the plasma membrane. In add ition, we show that trafficking of each protein to the plasma membrane depends on concomitant expression of the other protein. Finally, neit her protein could be immunoprecipitated from conditioned media, indica ting that neither is secreted. Taken together, these results suggest t hat the plasma membrane is the site at which 10.4K and 14.5K function to inhibit cytolysis by tumor necrosis factor and to down regulate the epidermal growth factor receptor.